Last reviewed · How we verify
Cord Tissue Mesenchymal Stromal Cells — Competitive Intelligence Brief
phase 2
Immunology
Biologic
Live · refreshed every 30 min
Target snapshot
Cord Tissue Mesenchymal Stromal Cells (Cord Tissue Mesenchymal Stromal Cells) — Joanne Kurtzberg, MD. Cord Tissue Mesenchymal Stromal Cells are thought to exert therapeutic effects through immunomodulation and tissue repair.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cord Tissue Mesenchymal Stromal Cells TARGET | Cord Tissue Mesenchymal Stromal Cells | Joanne Kurtzberg, MD | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cord Tissue Mesenchymal Stromal Cells CI watch — RSS
- Cord Tissue Mesenchymal Stromal Cells CI watch — Atom
- Cord Tissue Mesenchymal Stromal Cells CI watch — JSON
- Cord Tissue Mesenchymal Stromal Cells alone — RSS
Cite this brief
Drug Landscape (2026). Cord Tissue Mesenchymal Stromal Cells — Competitive Intelligence Brief. https://druglandscape.com/ci/cord-tissue-mesenchymal-stromal-cells. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab